We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Fetcroja

News List

Shionogi’s novel antibiotic added to UK’s pilot subscription reimbursement model pharmatimes
December 24, 2020
Shionogi’s novel antibiotic Fetcroja (cefiderocol) has been selected by the UK’s National Institute for Health and Care Excellence (NICE) and the National Health Service England and Improvement (NHSE&I) to be included in a pilot subscription ...
Shionogi launches novel antibiotic Fetcroja in the UK pharmatimes
September 16, 2020
Japanese pharma company Shionogi has announced that its new antibiotic Fetcroja (cefiderocol) is now available for use in the UK, the first country to launch the drug following its European Commission (EC) approval earlier this year.
CHMP recommends just two new meds in Feb meeting pharmatimes
March 06, 2020
The European Medicines Agency’s (EMA) human medicines committee (CHMP) has recommended just two new medicines for approval at its February 2020 meeting, as well as three extensions of pre-existing therapies.